cryptotanshinone has been researched along with Adenocarcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, L; Guo, C; Wan, L; Xin, B; Yang, Q; Zhang, H; Zhang, J | 1 |
| Chen, L; Chu, X; He, Z; Huang, G; Pan, Y; Song, H; Tao, L; Wang, R | 1 |
| Chang, C; Li, S; Lin, TH; Tsai, YC; Xu, D; Yeh, S; Yin, M; Zhang, C; Zhang, J | 1 |
3 other study(ies) available for cryptotanshinone and Adenocarcinoma
| Article | Year |
|---|---|
Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
Topics: Adenocarcinoma; Animals; Cachexia; Colonic Neoplasms; HEK293 Cells; HeLa Cells; Humans; Male; Mice, Inbred BALB C; Muscle Fibers, Skeletal; Muscle Proteins; Muscular Atrophy; Phenanthrenes; Phosphorylation; Signal Transduction; SKP Cullin F-Box Protein Ligases; STAT3 Transcription Factor; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Weight Loss | 2020 |
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cancer-Associated Fibroblasts; Cell Communication; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Interleukin-11; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phenanthrenes; Phosphorylation; Primary Cell Culture; Receptors, Interleukin-11; RNA, Small Interfering; Signal Transduction; STAT3 Transcription Factor; Survival Analysis; Xenograft Model Antitumor Assays | 2016 |
The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells.
Topics: Adenocarcinoma; Cell Line, Tumor; Estrogen Receptor alpha; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Proteins; Phenanthrenes; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Glucocorticoid; Receptors, Progesterone; Serine Endopeptidases | 2012 |